Insmed
(NASDAQ) INSM
Insmed Financials at a Glance
Market Cap
$24.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$819.56M
Net Income (TTM)
-$1.18B
EPS (TTM)
-$5.74
P/E Ratio
-19.65
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$112.81
Volume
1,674,721
Open
$113.21
Price
$112.81
Volume
1,674,721
Open
$113.21
Previous Close
$112.84
Daily Range
$111.47 - $114.69
52-Week Range
$90.39 - $212.75
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$112.81
Volume
1,674,721
Open
$113.21
Previous Close
$112.84
Daily Range
$111.47 - $114.69
52-Week Range
$90.39 - $212.75
Estimated Earnings Date
Aug 6, 2026
INSM News
INSM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Insmed
Industry
Biotechnology
Sector
Health CareEmployees
1,664
CEO
Will Lewis, MBA
Website
www.insmed.comHeadquarters
Bridgewater, NJ 08807, US
INSM Financials
Key Financial Metrics (TTM)
Gross Margin
81.56%
Operating Margin
-137.74%
Net Income Margin
-144.44%
Return on Equity
-130.11%
Return on Capital
-78.08%
Return on Assets
-57.02%
Earnings Yield
-5.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$24.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
216.75M
Volume
1.67M
Avg. Volume
3.74M
Financials (TTM)
Gross Profit
$668.40M
Operating Income
-$1.13B
EBITDA
-$1.08B
Operating Cash Flow
-$895.66M
Capital Expenditure
-$55.97M
Free Cash Flow
-$951.64M
Cash & ST Invst.
$1.22B
Total Debt
$748.44M
Insmed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$305.96M
+229.6%
Gross Profit
$256.46M
+258.5%
Gross Margin
83.82%
N/A
Market Cap
$24.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$19.24M
N/A
Employees
1,271
N/A
Net Income
-$163.56M
+36.3%
EBITDA
-$136.32M
+41.4%
Quarterly Fundamentals
Total Cash
$1.22B
+2.0%
Total Debt
$748.44M
-42.8%
Accounts Receivable
$178.56M
+274.0%
Inventory
$132.91M
+32.0%
Long Term Debt
$734.01M
-43.5%
Short Term Debt
$14.43M
+40.5%
Return on Assets
-57.02%
N/A
Return on Invested Capital
-65.83%
N/A
Free Cash Flow
-$226.22M
+16.9%
Operating Cash Flow
-$222.74M
+15.0%